BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7524841)

  • 1. CD34+ positive haemopoietic cells: biology and clinical applications.
    Holyoake TL; Alcorn MJ
    Blood Rev; 1994 Jun; 8(2):113-24. PubMed ID: 7524841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLe(x) expression of normal CD34 positive bone marrow haemopoietic progenitor cells.
    Karakantza M; Gibson FM; Cavenagh JD; Ball SE; Gordon MY; Gordon-Smith EC
    Br J Haematol; 1994 Apr; 86(4):883-6. PubMed ID: 7522525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CD34 antigen: structure, biology, and potential clinical applications.
    Sutherland DR; Keating A
    J Hematother; 1992; 1(2):115-29. PubMed ID: 1285404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive stem cell selection--basic science.
    Civin CI; Strauss LC; Fackler MJ; Trischmann TM; Wiley JM; Loken MR
    Prog Clin Biol Res; 1990; 333():387-401; discussion 402. PubMed ID: 1689854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting gene expression to haemopoietic stem cells: a chromatin-dependent upstream element mediates cell type-specific expression of the stem cell antigen CD34.
    May G; Enver T
    EMBO J; 1995 Feb; 14(3):564-74. PubMed ID: 7532132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CD34 hemopoietic progenitor cell associated antigen: biology and clinical applications.
    Silvestri F; Banavali S; Baccarani M; Preisler HD
    Haematologica; 1992; 77(3):265-73. PubMed ID: 1385274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of marrow reserve from dose-intensified chemotherapy results in impaired hematopoietic reconstitution after autologous transplantation: CD34(+), CD34(+)38(-), and week-6 CAFC assays predict poor engraftment.
    Robinson SN; Freedman AS; Neuberg DS; Nadler LM; Mauch PM
    Exp Hematol; 2000 Dec; 28(12):1325-33. PubMed ID: 11146154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD34+ selected cells in clinical transplantation.
    Collins RH
    Stem Cells; 1994 Nov; 12(6):577-85. PubMed ID: 7533577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of AC133 vs. CD34 in acute childhood leukemias].
    Ebener U; Brinkmann A; Zotova V; Niegemann E; Wehner S
    Klin Padiatr; 2000; 212(3):90-8. PubMed ID: 10916777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
    Haas R; Murea S
    Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The haemopoietic progenitor cell antigen.
    Parikh PM; Banavali SD; Rao SG; Advani SH
    Natl Med J India; 1994; 7(1):22-4. PubMed ID: 7512398
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiparameter flow-cytometrical quantitation of circulating CD34(+)-cells: correlation to the quantitation of circulating haemopoietic progenitor cells by in vitro colony-assay.
    Serke S; Säuberlich S; Huhn D
    Br J Haematol; 1991 Apr; 77(4):453-9. PubMed ID: 1709040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients.
    Feller N; van der Pol MA; Waaijman T; Weijers GW; Westra G; Ossenkoppele GJ; Schuurhuis GJ
    Clin Cancer Res; 2005 Jul; 11(13):4793-801. PubMed ID: 16000576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combination of CD34 selection and complement-mediated immunopurging (anti-CD15 monoclonal antibody) eliminates tumor cells while sparing normal progenitor cells.
    Nimgaonkar M; Kemp A; Lancia J; Ball ED
    J Hematother; 1996 Feb; 5(1):39-48. PubMed ID: 8646480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and positive selection of human progenitor/stem cells for bone marrow transplantation.
    Civin CI
    Prog Clin Biol Res; 1992; 377():461-72; discussion 473. PubMed ID: 1279715
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of homeobox genes expressed in human haemopoietic progenitor cells.
    Moretti P; Simmons P; Thomas P; Haylock D; Rathjen P; Vadas M; D'Andrea R
    Gene; 1994 Jul; 144(2):213-9. PubMed ID: 7518789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotyping of peripheral blood hemopoietic progenitor cells--in vitro cultures using CD34-/CD33-immunomagnetic purging.
    Serke S; Abe Y; Kirsch A; Huhn D
    Eur J Haematol; 1991 Nov; 47(5):361-6. PubMed ID: 1722174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of bone morphogenetic protein-6 on haemopoietic stem cells and cytokine production in normal human bone marrow stroma.
    Ahmed N; Sammons J; Carson RJ; Khokher MA; Hassan HT
    Cell Biol Int; 2001; 25(5):429-35. PubMed ID: 11401330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human immunodeficiency virus (HIV)-type 1 coreceptor CXCR-4 (fusin) is preferentially expressed on the more immature CD34+ hematopoietic stem cells.
    Viardot A; Kronenwett R; Deichmann M; Haas R
    Ann Hematol; 1998 Nov; 77(5):193-7. PubMed ID: 9858143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemopoietic progenitor cell differentiation: flow cytometric assessment in bone marrow and thymus.
    Tjønnfjord GE; Steen R; Veiby OP; Mørkrid L; Egeland T
    Br J Haematol; 1995 Dec; 91(4):1006-16. PubMed ID: 8547112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.